Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]

We present a follow up contribution to further complement a previous commentary on the activity cliff concept and recent advances in activity cliff research. Activity cliffs have originally been defined as pairs of structurally similar compounds that display a large difference in potency against a g...

Full description

Bibliographic Details
Main Authors: Dagmar Stumpfe, Antonio de la Vega de León, Dilyana Dimova, Jürgen Bajorath
Format: Article
Language:English
Published: F1000 Research Ltd 2014-03-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/3-75/v1
_version_ 1818042865988665344
author Dagmar Stumpfe
Antonio de la Vega de León
Dilyana Dimova
Jürgen Bajorath
author_facet Dagmar Stumpfe
Antonio de la Vega de León
Dilyana Dimova
Jürgen Bajorath
author_sort Dagmar Stumpfe
collection DOAJ
description We present a follow up contribution to further complement a previous commentary on the activity cliff concept and recent advances in activity cliff research. Activity cliffs have originally been defined as pairs of structurally similar compounds that display a large difference in potency against a given target. For medicinal chemistry, activity cliffs are of high interest because structure-activity relationship (SAR) determinants can often be deduced from them. Herein, we present up-to-date results of systematic analyses of the ligand efficiency and lipophilic efficiency relationships between activity cliff-forming compounds, which further increase their attractiveness for the practice of medicinal chemistry. In addition, we summarize the results of a new analysis of coordinated activity cliffs and clusters they form. Taken together, these findings considerably add to our evaluation and current understanding of the activity cliff concept. The results should be viewed in light of the previous commentary article.
first_indexed 2024-12-10T08:53:07Z
format Article
id doaj.art-a2582ad6e91248e98bc7436fed99ad08
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-12-10T08:53:07Z
publishDate 2014-03-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-a2582ad6e91248e98bc7436fed99ad082022-12-22T01:55:31ZengF1000 Research LtdF1000Research2046-14022014-03-01310.12688/f1000research.3788.14057Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]Dagmar Stumpfe0Antonio de la Vega de León1Dilyana Dimova2Jürgen Bajorath3Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, D-53113, GermanyDepartment of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, D-53113, GermanyDepartment of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, D-53113, GermanyDepartment of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, D-53113, GermanyWe present a follow up contribution to further complement a previous commentary on the activity cliff concept and recent advances in activity cliff research. Activity cliffs have originally been defined as pairs of structurally similar compounds that display a large difference in potency against a given target. For medicinal chemistry, activity cliffs are of high interest because structure-activity relationship (SAR) determinants can often be deduced from them. Herein, we present up-to-date results of systematic analyses of the ligand efficiency and lipophilic efficiency relationships between activity cliff-forming compounds, which further increase their attractiveness for the practice of medicinal chemistry. In addition, we summarize the results of a new analysis of coordinated activity cliffs and clusters they form. Taken together, these findings considerably add to our evaluation and current understanding of the activity cliff concept. The results should be viewed in light of the previous commentary article.http://f1000research.com/articles/3-75/v1Drug Discovery & DesignMacromolecular ChemistryMolecular PharmacologyPharmacogenomicsPharmacokinetics & Drug DeliverySmall Molecule Chemistry
spellingShingle Dagmar Stumpfe
Antonio de la Vega de León
Dilyana Dimova
Jürgen Bajorath
Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
F1000Research
Drug Discovery & Design
Macromolecular Chemistry
Molecular Pharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Small Molecule Chemistry
title Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
title_full Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
title_fullStr Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
title_full_unstemmed Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
title_short Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p]
title_sort advancing the activity cliff concept part ii v1 ref status indexed http f1000r es 34p
topic Drug Discovery & Design
Macromolecular Chemistry
Molecular Pharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Small Molecule Chemistry
url http://f1000research.com/articles/3-75/v1
work_keys_str_mv AT dagmarstumpfe advancingtheactivitycliffconceptpartiiv1refstatusindexedhttpf1000res34p
AT antoniodelavegadeleon advancingtheactivitycliffconceptpartiiv1refstatusindexedhttpf1000res34p
AT dilyanadimova advancingtheactivitycliffconceptpartiiv1refstatusindexedhttpf1000res34p
AT jurgenbajorath advancingtheactivitycliffconceptpartiiv1refstatusindexedhttpf1000res34p